Work

Novel Fc-Engineered Anti-B Cell Maturation Antigen-Monomethyl Auristatin F Antibody-Drug Conjugate (GSK2857916) Induces Potent and Selective Anti-Multiple Myeloma Activity Via Enhanced Effector Function and Direct Tumor Cell Killing

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.877.877

Authors: Yu-Tzu Tai, Chirag Acharya, Mike Y Zhong, Michele Cea, Antonia Cagnetta, Patrick A Mayes, Jenny L Craigen, Louise Gliddon, James Smothers, Amanda L Christie, Andrew L. Kung, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson

Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, GlaxoSmithKline (United States), GlaxoSmithKline (United Kingdom), Harvard University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2530060405

FWCI: 0.475

Cites:

Cited by: 3

Related to: 10